Sentences with phrase «pheochromocytoma in»

Management of Pheochromocytoma in Dakar: Diagnostic and Therapeutic Advances throughout 16 Cases

Sept 27, 2007 New England Journal of Medicine - Genetics Detective Work Confirms MEN 2 - related Pheochromocytoma In a fascinating medico - historical reconstruction published in the September 27th issue of the New England Journal of Medicine, Charis Eng, M.D., Ph.D., Chair, Genomic Medicine Institute, and collaborators tracked down the original autopsy report of a German woman diagnosed more than 120 years ago, who had the first described case of what is now known as pheochromocytoma.

Not exact matches

In the CPG, the Endocrine Society recommends that initial testing for pheochromocytomas and paragangliomas include blood or urine tests for metanephrines — the products left behind when the body metabolizes epinephrine and norepinephrine.

The CPG, entitled «Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline,» appeared in the June 2014 issue of the Journal of Clinical Endocrinology and Metabolism (JCEM), a publication of the Endocrine Society.

«Correctly diagnosing pheochromocytomas and paragangliomas is extremely important,» said Jacques W.M. Lenders, MD, PhD, FRCP, of Radboud University in Nijmegen, the Netherlands, and chair of the task force that authored the guideline.

Scientists have discovered a new «mastermind fusion gene» may be associated with a rare cancer - causing tumor — pheochromocytomas («pheo») and paragangliomas, according to a study published Feb. 13 in Cancer Cell, by researchers at the Uniformed Services University (USU) and the National Cancer Institutes» The Cancer Genome Atlas.

[See Neumann HP, et al.Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C. Evidence of MEN - 2 in the original description of classic pheochromocytoma.

206/3: 00 Assessing the clinical validity of genes implicated in hereditary pheochromocytoma / paraganglioma and pancreatic cancer using the ClinGen framework.

Consult a Physician before using this product if you have, or have a family history of, including but not limited to Phenylketonuria, high blood pressure, cardiac arrhythmias, heart, liver, kidney, thyroid, or psychiatric disease, pheochromocytoma, diabetes, asthma, recurrent headaches, anemia, nervousness, anxiety, depression or other psychiatric condition, peptic ulcers, Parkinson's disease, glaucoma, difficulty in urinating, prostate enlargement, or seizure disorder, or if you are using any other dietary supplement or over-the-counter drug containing ephedrine, pseudo - ephedrine, or phenylpropanolamine (ingredients found in certain allergy, asthma, cough or cold, and weight control products).

Avoid using in pregnant or nursing pets Pets with pheochromocytoma (a rare adrenal tumor) Pets with a history of seizures.

Pheochromocytoma presenting as acute retroperitoneal hemorrhage in a dog.

Adrenal medullary pheochromocytomas are most common in Boxer dogs.

Adrenal medullary tumors are rare but pheochromocytomas are the most common type and usually occur in middle aged to older dogs.